Insider · CIK 0001871002

Gassert Chad

Reports to the SEC for 1 company · BAUDETTE, MN

sec.gov

Transactions

Companies

Filings

CIK

0001871002

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - CORP. DEV. & STRATEGY	FTax Payment	−2,221 sh	$73.90	−$164K	74,916
2026-02-26	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+11.1K sh	$77.15	+$858K	77,137
2026-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - CORP. DEV. & STRATEGY	FTax Payment	−1,717 sh	$77.36	−$133K	66,021
2026-02-12	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - CORP. DEV. & STRATEGY	FTax Payment	−1,608 sh	$76.70	−$123K	67,738
2026-02-11	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - CORP. DEV. & STRATEGY	FTax Payment	−4,269 sh	$76.25	−$326K	69,346
2025-11-13	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−94 sh	$88.00	−$8,272	158,490
2025-11-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−14.6K sh	$89.07	−$1.3M	158,584
2025-08-15	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$86.97	−$1.74M	173,226
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+9,574 sh	—	—	73,615
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+14.4K sh	—	—	64,041
2024-07-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$63.44	−$1.27M	193,226
2024-06-03	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$64.41	−$1.29M	213,226
2024-05-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$66.62	−$1.33M	233,226
2024-04-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$67.25	−$1.35M	253,226
2024-03-11	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$65.81	−$1.32M	273,226
2024-02-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP - CORP. DEV. & STRATEGY	FTax Payment	−1,635 sh	$67.67	−$111K	49,679
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+8,946 sh	—	—	51,314
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+13.4K sh	—	—	42,368
2023-10-02	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$56.48	−$1.13M	293,226
2023-09-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$64.70	−$1.29M	313,226
2023-08-01	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$51.06	−$1.02M	333,226
2023-07-03	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$53.43	−$1.07M	353,226
2023-06-22	ANIPANI PHARMACEUTICALS INCS Sale	SVP - CORP. DEV. & STRATEGY	SSale	−20K sh	$51.32	−$1.03M	373,226
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+17.4K sh	—	—	17,369
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+11.6K sh	—	—	28,947
2022-03-21	ANIPANI PHARMACEUTICALS INCP Purchase	SVP - CORP. DEV. & STRATEGY	PPurchase	+5,000 sh	$27.87	+$139K	393,226
2022-03-18	ANIPANI PHARMACEUTICALS INCP Purchase	SVP - CORP. DEV. & STRATEGY	PPurchase	+5,000 sh	$27.15	+$136K	388,226
2021-11-19	ANIPANI PHARMACEUTICALS INCA Award	SVP - CORP. DEV. & STRATEGY	AAward	+383K sh	—	—	383,226

Recent filings

Accepted (ET)
Mar 24
Gassert Chad0001871002-26-000006
SEC(opens sec.gov)
Feb 174
Gassert Chad0001871002-26-000004
SEC(opens sec.gov)
Feb 134
Gassert Chad0001871002-26-000002
SEC(opens sec.gov)
Nov 144
Gassert Chad0001871002-25-000007
SEC(opens sec.gov)
Aug 184
Gassert Chad0001871002-25-000004
SEC(opens sec.gov)
Feb 184
Gassert Chad0001871002-25-000002
SEC(opens sec.gov)
Jul 24
Gassert Chad0001871002-24-000014
SEC(opens sec.gov)
Jun 44
Gassert Chad0001871002-24-000012
SEC(opens sec.gov)
May 34
Gassert Chad0001871002-24-000010
SEC(opens sec.gov)
Apr 24
Gassert Chad0001871002-24-000008
SEC(opens sec.gov)
Mar 134
Gassert Chad0001871002-24-000006
SEC(opens sec.gov)
Mar 14
Gassert Chad0001871002-24-000004
SEC(opens sec.gov)
Feb 164
Gassert Chad0001871002-24-000002
SEC(opens sec.gov)
Oct 34
Gassert Chad0001871002-23-000009
SEC(opens sec.gov)
Sep 54
Gassert Chad0001871002-23-000006
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCSVP - CORP. DEV. & STRATEGYANIP

Address

C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST

BAUDETTE, MN, 56623